| P50 | author | David A. Bluemke | Q39818611 |
| | Jeremy Burt | Q47881625 |
| | Anneline S J M Te Riele | Q84443048 |
| | Daniel P Judge | Q84820718 |
| | Cynthia A James | Q89438584 |
| | Harikrishna Tandri | Q90794759 |
| P2093 | author name string | Hugh Calkins | |
| | Ihab R Kamel | |
| | Stefan L Zimmerman | |
| | Neda Rastegar | |
| | Crystal Tichnell | |
| | Brittney Murray | |
| | Aditya Bhonsale | |
| | Srinivasa Madhavan | |
| P2860 | cites work | Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q24299388 |
| | Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy | Q24306039 |
| | Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy | Q24310389 |
| | Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study | Q28238424 |
| | Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes | Q28254076 |
| | Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28266152 |
| | Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2 | Q28267888 |
| | Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28268639 |
| | Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy | Q28288328 |
| | Dispersion of ventricular depolarization-repolarization: a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy | Q33146513 |
| | Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. | Q33150735 |
| | Arrhythmogenic right ventricular dysplasia: a United States experience | Q33153393 |
| | Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia | Q33159168 |
| | Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases | Q33161062 |
| | Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). | Q33910305 |
| | Right ventricular dysplasia: a report of 24 adult cases | Q34714742 |
| | Shared desmosome gene findings in early and late onset arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q35110260 |
| | Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? | Q36041405 |
| | The utility of magnetic resonance imaging in the evaluation of arrhythmogenic right ventricular cardiomyopathy | Q37087188 |
| | HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). | Q37905310 |
| | Pathophysiology of arrhythmogenic cardiomyopathy | Q37962327 |
| | Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature | Q37994613 |
| | Relative contribution of changes in sodium current versus intercellular coupling on reentry initiation in 2-dimensional preparations of plakophilin-2-deficient cardiac cells | Q38793669 |
| | Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy | Q43615832 |
| | Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study | Q44589388 |
| | Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. | Q51671006 |
| | Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. | Q51704331 |
| | Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. | Q53291585 |
| | Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. | Q55638651 |
| | Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: Insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study | Q57736261 |
| | Cardiovascular Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy Revisited | Q57901962 |
| | Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. | Q64934138 |
| | Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention | Q84974205 |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiac magnetic resonance imaging | Q5038325 |
| P304 | page(s) | 1761-1769 | |
| P577 | publication date | 2013-06-27 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers | |
| P478 | volume | 62 | |